Related Experiment Video
Updated: Jan 30, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
Invasive pneumococcal disease in relation to vaccine type serotypes
Paeton L Wantuch1, Fikri Y Avci1
1a Department of Biochemistry and Molecular Biology, Center for Molecular Medicine and Complex Carbohydrate Research Center , University of Georgia , Athens , GA , USA.
Despite widespread vaccination, Streptococcus pneumoniae infections remain a global health burden. Current vaccines are surprisingly ineffective against prevalent serotypes, necessitating novel strategies for invasive pneumococcal disease (IPD) control.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Four Streptococcus pneumoniae vaccines have been developed since 1983.
- Despite vaccination, S. pneumoniae causes significant global morbidity and mortality.
Discussion:
- Invasive pneumococcal disease (IPD) is still caused by serotypes targeted by current vaccines, like 3 and 19A.
- Non-vaccine serotypes, such as 35B, are emerging and increasing.
Key Insights:
- Current vaccines exhibit limited efficacy against dominant S. pneumoniae serotypes.
- A rise in non-vaccine serotype IPD indicates evolving bacterial resistance to vaccination.
Outlook:
- Further research is crucial for designing improved conjugate vaccines.
- Novel strategies are required to effectively combat invasive pneumococcal disease.
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Relative Risk
Relative Velocity in One Dimension
Relative Frequency Histogram
Relative Velocity in Two Dimensions

